Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil LevelsLeif Bjermer, Matthew Germinaro, Catherine Lemière et al.|CHEST Journal|2016Cited by 426
Eosinophilic and Noneosinophilic AsthmaLiam G. Heaney, David Price, Mona Al‐Ahmad et al.|CHEST Journal|2021Cited by 262
Long-term Safety and Efficacy of Reslizumab in Patients with Eosinophilic AsthmaKevin R. Murphy, Mario Castro, Joshua Jacobs et al.|The Journal of Allergy and Clinical Immunology In Practice|2017Cited by 146